SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-113592
Filing Date
2020-04-21
Accepted
2020-04-21 16:31:33
Documents
4
Period of Report
2020-06-09
Effectiveness Date
2020-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d903089ddef14a.htm DEF 14A 313216
2 GRAPHIC g903089g21f86.jpg GRAPHIC 169973
3 GRAPHIC g903089g59p34.jpg GRAPHIC 88843
4 GRAPHIC g903089g93e54.jpg GRAPHIC 138334
  Complete submission text file 0001193125-20-113592.txt   861671
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36644 | Film No.: 20805520
SIC: 2834 Pharmaceutical Preparations